Comparison of Treadmill and Outdoor Walking in Patients With Fibromyalgia
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Walking exercises with treadmill, Walking exercises at open air place.
- Who it may be relevant to
- Registry conditions: Fibromyalgia. Basic parameters: 25 years — 55 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Evaluation of the Effect of Open-Air Walking Supported by Treadmill and Mobile Application on Cardiopulmonary Function and Quality of Life in Patients With Fibromyalgia Syndrome
Overview
While walking exercises performed outdoors are important within the scope of aerobic exercise, the continuity of outdoor walking exercises can be negatively affected by different weather conditions. Walking exercises performed indoors on a treadmill are a good option for patients in terms of increasing exercise continuity and patient compliance. Walking outdoors supported by a treadmill and mobile application may increase aerobic capacity and quality of life in patients with fibromyalgia syndrome, as well as reduce kinesiophobia.
Interventions
- Other Walking exercises with treadmill
Patients will be enrolled in a treadmill exercise program in the cardiopulmonary exercise unit for 45 minutes, 3 days a week for 4 weeks. - Other Walking exercises at open air place
Patients will walk briskly outdoors for 45 minutes, 3 days a week for 4 weeks. Patients will receive notifications via a mobile app reminding them of their daily walk, and they will be asked to log their walks in the mobile app.
Primary outcome measures
- 6-minute walk test [Time frame: First day of treatment, at the end of 4 week]
Secondary outcome measures (5)
- Fibromyalgia Impact Questionnaire (FIQ) [Time frame: First day of treatment, at the end of 4 week]
- Measurement of maximum inspiratory and expiratory pressure (MIP) and (MEP) [Time frame: First day of treatment, at the end of 4 week]
- Beck Depression Scale [Time frame: First day of treatment, at the end of 4 week]
- Fatigue Impact Scale [Time frame: First day of treatment, at the end of 4 week]
- Short Form-36 (SF-36) [Time frame: First day of treatment, at the end of 4 week]
Eligibility criteria
Inclusion criteria
- Be between the ages of 25 and 55
- Be female
- Have not engaged in regular physical activity for the past 3 months
- Have been using the same medical treatment for at least 1 month prior to the study (amitriptyline, duloxetine/milnacipran, pregabalin, cyclobenzaprine)
- Volunteering to participate in the study
- The patient's cognitive status being suitable for using a mobile application
- The patient agreeing to the 'Personal Data Protection Law Information Text' in order to use the mobile application
Exclusion criteria
- History of cardiac or pulmonary disease
- Changes in medical treatment during the study period
- Use of different injection methods (ozone therapy, neural therapy, acupuncture, etc.) at least 3 months prior to the study or during the study period
- History of rheumatological disease
- Pregnancy or breastfeeding
- History of malignancy
- Presence of psychiatric or neurological disease
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Turkey (Türkiye) · 1 center
- Etlik City Hospital — Ankara
Identifiers
NCT: NCT07228897 · AEŞH-EK-2025-182